Venovenous extracorporeal membrane oxygenation treatment in a low-volume and geographically isolated cardiothoracic centre.
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Your vote was cast
Thank you for your feedback
Thank you for your feedback
AuthorsIngvarsdottir, Inga L
Sigurdsson, Martin I
MetadataShow full item record
CitationVenovenous extracorporeal membrane oxygenation treatment in a low-volume and geographically isolated cardiothoracic centre. 2019, 63(7):879-884 Acta Anaesthesiol Scand
AbstractBACKGROUND: Extracorporeal membrane oxygenation (ECMO) treatment is generally offered in large tertiary cardiothoracic referral centres. Here we present the indications and outcome of venovenous-ECMO (VV-ECMO) treatment in a low-volume, geographically isolated single-centre in Iceland, a country of 350 000 inhabitants. Our hypothesis was that patient survival in such a centre can be similar to that at high-volume centres. METHODS: A retrospective study that included all patients treated with VV-ECMO in Iceland from 1991-2016 (n = 17). Information on demographics, indications and in-hospital survival was collected from patient charts and APACHE II and Murray scores were calculated. Information on long-term survival was collected from a centralized registry. RESULTS: Seventeen patients were treated with VV-ECMO (nine males, median age 33 years, range 14-74), the indication for 16 patients was severe acute respiratory distress syndrome, most often following pneumonia (n = 6), H1N1-infection (n = 3) or drowning (n = 2). Median APACHE-II and Murray-scores were 20 and 3.5, respectively, and median duration of VV-ECMO treatment was 9 days (range 2-40 days). In total 11 patients (64,7%) survived the treatment, with 10 patients (58,8%) surviving hospital discharge, all of who were still alive at long-term follow-up, with a median follow-up time of 9 years (August 15th, 2017). CONCLUSION: Venovenous-ECMO service can be provided in a low-volume and geographically isolated centre, like Iceland, with short- and long-term outcomes comparable to larger centres.
DescriptionTo access publisher's full text version of this article click on the hyperlink below
- The impacts of baseline ventilator parameters on hospital mortality in acute respiratory distress syndrome treated with venovenous extracorporeal membrane oxygenation: a retrospective cohort study.
- Authors: Wu MY, Chang YS, Huang CC, Wu TI, Lin PJ
- Issue date: 2017 Dec 8
- [Predictive values of different critical scoring systems for mortality in patients with severe acute respiratory failure supported by extracorporeal membrane oxygenation].
- Authors: Wang R, Sun B, Li XY, He HY, Tang X, Zhan QY, Tong ZH
- Issue date: 2016 Sep
- Venovenous Versus Venoarterial Extracorporeal Membrane Oxygenation for Adult Patients With Acute Respiratory Distress Syndrome Requiring Precannulation Hemodynamic Support: A Review of the ELSO Registry.
- Authors: Kon ZN, Bittle GJ, Pasrija C, Pham SM, Mazzeffi MA, Herr DL, Sanchez PG, Griffith BP
- Issue date: 2017 Aug
- Extracorporeal Membrane Oxygenation and Interfacility Transfer: A Regional Referral Experience.
- Authors: Ranney DN, Bonadonna D, Yerokun BA, Mulvihill MS, Al-Rawas N, Weykamp M, Gunasingha RM, Bartz RR, Haney JC, Daneshmand MA
- Issue date: 2017 Nov
- The lung rescue unit-Does a dedicated intensive care unit for venovenous extracorporeal membrane oxygenation improve survival to discharge?
- Authors: Menaker J, Dolly K, Rector R, Kufera J, Lee EE, Tabatabai A, Rabinowitz RP, Kon ZN, Sanchez P, Pham S, Herr DL, O'Connor JV, Stein DM, Scalea TM
- Issue date: 2017 Sep